Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$744K Sell
17,447
-8,583
-33% -$384K 0.39% 54
2026
Q1
$1.25M Buy
26,030
+17,050
+190% +$795K 0.69% 19
2025
Q4
$435K Buy
8,980
+1,522
+20% +$75.4K 0.2% 145
2025
Q3
$352K Sell
7,458
-1,552
-17% -$74.9K 0.15% 219
2025
Q2
$435K Buy
+9,010
New +$460K 0.24% 129
2025
Q1
Sell
-4,180
Closed -$202K 1326
2024
Q4
$202K Buy
+4,180
New +$213K 0.2% 112

Other funds holding SNY

R Squared's SNY Position: Q2 2026 in Review

R Squared reduced its Sanofi (SNY) stake by 33% in Q2 2026, selling an estimated $384K and leaving 17,447 shares worth $744K. The position accounts for 0.39% of the portfolio, ranked #54.

R Squared first reported a position in SNY in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.25M in Q1 2026. 715 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • R Squared held 17,447 shares of Sanofi worth $744K as of Q2 2026.
  • R Squared sold 8,583 Sanofi shares in Q2 2026, an estimated $384K.
  • Sanofi made up 0.39% of R Squared's portfolio in Q2 2026, its #54 holding.
  • R Squared first reported a position in Sanofi in Q4 2024 and has held it in 6 quarters since.
  • R Squared's Sanofi position peaked at $1.25M in Q1 2026.
  • 715 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.